---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-21-001314"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:41:51.433161+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Charles River Q3 revenue $895.9M (+20.5% YoY); non-GAAP EPS $2.70; updates 2021 guidance

## Summary
- Revenue $895.9M, +20.5% YoY; organic growth 13.6% with contributions from all three segments.
- GAAP EPS $2.01 (-1.0% YoY) includes $0.15 loss from venture investments; non-GAAP EPS $2.70 (+15.9%).
- RMS segment revenue $171.3M (+12.7% YoY); DSA $531.8M (+15.3%); Manufacturing $192.9M (+48.1%).
- 2021 guidance: reported revenue growth 19.5%-20.5% (from 20.5%-22.5%); GAAP EPS raised to $7.05-$7.15; non-GAAP EPS $10.20-$10.30.
- Completed divestitures of RMS Japan and CDMO Sweden on Oct 12; reduces Q4 revenue ~$20M and non-GAAP EPS <$0.10.

## SEC filing metadata
- accession: 0001157523-21-001314
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000115752321001314/0001157523-21-001314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000115752321001314/a52520056.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-21-001314
- JSON: https://secwatch.observer/filing/0001157523-21-001314.json
- Plain text: https://secwatch.observer/filing/0001157523-21-001314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.